1. Academic Validation
  2. Design, synthesis, and biological activity of novel Magmas inhibitors

Design, synthesis, and biological activity of novel Magmas inhibitors

  • Bioorg Med Chem Lett. 2011 Jun 1;21(11):3479-82. doi: 10.1016/j.bmcl.2011.03.050.
Paul T Jubinsky 1 Mary K Short Mohmoud Ghanem Bhaskar C Das
Affiliations

Affiliation

  • 1 Pediatric Hematology/Oncology, Yale University Medical School, New Haven, CT 06510, United States. [email protected]
Abstract

Magmas (mitochondria associated, granulocyte-macrophage colony stimulating factor signaling molecule), is a highly conserved and essential gene, expressed in all cell types. We designed and synthesized several small molecule Magmas inhibitors (SMMI) and assayed their effects on proliferation in yeast. We found that the most active compound 9 inhibited growth at the 4 μM scale. This compound was shown by fluorometric titration to bind to Magmas with a K(d)=33 μM. Target specificity of the lead compound was established by demonstrating direct binding of the compound to Magmas and by genetic studies. Molecular modeling suggested that the inhibitor bound at the predicted site in Magmas.

Figures
Products